[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100560493":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":22,"locations":28,"responsibleParty":45,"collaborators":10,"id":47,"slug":10,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":10,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":31,"whyStopped":10,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Sanoculis Ltd","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Inferonasal MIMS Surgery Cohort",null,"Cohort that includes subjects that have undergone the MIMS® inferonasal surgery.",[13],"Device: Inferonasal Minimally Invasive Micro Sclerostomy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Inferonasal Minimally Invasive Micro Sclerostomy","The Inferonasal MIMS® procedure uses the proprietary MIMS® device, which creates a sclerostomy in the inferonasal quadrant of the eye.",[9],[21],"Inferonasal MIMS",[23],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},"Khan Lau, OD","CONTACT","8082862666","khan@sanoculis.com",[29],{"facility":30,"status":31,"city":32,"state":10,"zip":10,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"S. Malayan Eye Center","RECRUITING","Yerevan","Armenia","AM",{"type":36,"coordinates":37},"Point",[38,39],44.5126,40.17765,{"lat":39,"lon":38},[42],{"name":43,"role":25,"phone":44,"phoneExt":10,"email":10},"Lilit A Voskanyan, MD","+374-10-34-49-44",{"type":46,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100560493",false,"NCT06577857","Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study","Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure: Long-Term Follow-Up Extension Study","Inclusion Criteria:\n\n1\\. Subject who underwent MIMS® inferonasal procedure, and surgery was performed not earlier than 24 months from enrollment","ALL","40 Years","85 Years",{"count":57,"type":58},53,"ESTIMATED","OBSERVATIONAL","A long-term (24 and 30 months) follow-up extension, prospective, non-interventional, open label study for data collection from subjects who underwent prior MIMS® inferonasal surgery, in continuation of the previous clinical investigation with the MIMS® Device (MMS-EEU-5).",[62],"Open Angle Glaucoma",[64,65,66,67,68,69,70],"Intraocular Pressure","MIMS","Inferonasal","Minimally Invasive Glaucoma Surgery","Trabeculectomy","Sclerostomy","MIGS","2024-09-24",{"date":73,"type":74},"2024-09-26","ACTUAL",{"date":76,"type":74},"2022-11-04",{"date":78,"type":58},"2025-06-30",{"name":5,"class":6},1]